Report Detail
Asia Pacific Cell Line Development Market to 2027 - Regional Analysis and Forecasts by Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bioproduction and Tissue Engineering); and Geography
- RnM3926451 |
- 13 March, 2020 |
- Global |
- 155 Pages |
- The Insight Partners |
- Biotechnology
The Asia Pacific cell line development market is expected to reach US$ 2,813.78 Mn in 2027 from US$ 987.48 Mn in 2019. The market is estimated to grow with a CAGR of 14.0% from 2020-2027.
The growth of the cell line development market is primarily attributed to the increasing foreign direct investments in these countries, highly skilled, efficient, and a large number of human resources, streamlining government policies resulting in high expenditures for the biotechnology sector.
In the last few years, stem cell research became a significant field in the Asia Pacific medical sector, experiencing good development vision for the treatment of some challenging diseases. The government of the country organized various awareness programs for stem cell research. Moreover, the growing number of players operating across the country manufactures products for cell line development. The countries such as Australia, India, and South Korea are estimated to serve various growth opportunities due to the rising development in the biotechnology sector.
Moreover, the companies are performing various activities for the cell line development market, for instance, Selexis, Carestream Avacta, JSR Life Sciences. has done recent developments for products.
In 2018, the recombinant cell line segment held the most significant market share of the cell line development market, by type. This segment is also anticipated to dominate the market in 2027 owing to its popularity among manufacturers for the production of therapeutic recombinant proteins. The hybridomas segment is anticipated to witness growth at a significant rate during the forecast period.
The Japan cell line development market is dominated by intraoral media and reagent segment in 2019 with a considerable market share, by product. This segment is also predicted to dominate the market in 2027. Also, media and reagent segment is anticipated to witness growth at a significant rate during the forecast period, owing to the increasing research activities in biotechnology sector.
In 2019, the Bioproduction segment held a considerable market of the cell line development market, by the application. This segment is also predicted to dominate the market in 2027 owing to higher demand of biologics. However, the drug discovery segment is anticipated to witness growth at a significant rate during the forecast period.
Some of the major primary and secondary sources for cell line development included in the report are Chinese Academy of Sciences, Council of Scientific and Industrial Research, and others.
TABLE OF CONTENTS
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
2. Asia Pacific Cell Line Development Market – Key Takeaways
3. Asia Pacific Cell Line Development Market – Market Landscape
- 3.1 Overview
- 3.2 Market Segmentation
- 3.2.1 Asia Pacific Cell Line Development Market – By Type
- 3.2.2 Asia Pacific Cell Line Development Market – By Product
- 3.2.3 Asia Pacific Cell Line Development Market – By Application
- 3.2.4 Asia Pacific Cell Line Development Market – By Country
- 3.3 PEST Analysis
- 3.3.1 Asia Pacific – PEST Analysis
4. Asia Pacific Cell Line Development Market- Key Market Dynamics
- 4.1 Key Market Drivers
- 4.1.1 Evolving Biopharma Sector in the Asia Pacific
- 4.1.2 Rising Incidence of Chronic Diseases
- 4.2 Key Market Restraints
- 4.2.1 Risk Associated with Cell Line Contamination
- 4.3 Key Market Opportunities
- 4.3.1 Emerging Markets in the region
- 4.4 future Trends
- 4.4.1 Consistent Research in Drug Discovery Activities
- 4.5 Impact analysis
5. Cell Line Development Market – Asia Pacific Analysis
- 5.1 Asia Pacific Cell Line Development Market Revenue Forecasts and Analysis
- 5.2 Market positioning
- 5.3 Performance of Key Players
- 5.3.1 Merck KGaA
- 5.3.2 Thermo Fisher Scientific Inc.
- 5.4 Expert Opinions
6. Asia Pacific Cell Line Development Market Analysis – By Type
- 6.1 Overview
- 6.2 Asia Pacific Cell Line Development Market, BY type, 2018 & 2027 (%)
- 6.3 Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By type (US$ Mn)
- 6.4 Recombinant Cell Line Market
- 6.4.1 Overview
- 6.4.2 Asia Pacific Recombinant Cell Line Market Revenue And Forecasts To 2027(US$ Mn)
- 6.5 Hybridomas
- 6.5.1 Overview
- 6.5.2 Asia Pacific Hybridoma Market Revenue And Forecasts To 2027 (US$ Mn)
- 6.6 Primary Cell Line
- 6.6.1 Overview
- 6.6.2 Asia Pacific Primary Cell Line Market Revenue and Forecasts to 2027 (US$ Mn)
- 6.7 Continuous Cell Lines
- 6.7.1 Overview
- 6.7.2 Asia Pacific Continuous Cell Lines Market Revenue and Forecasts to 2027 (US$ Mn)
7. Asia Pacific Cell Line Development Market Analysis – By Product
- 7.1 Overview
- 7.2 Asia Pacific Cell Line Development Market, BY product, 2018 & 2027 (%)
- 7.3 Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By product (US$ Mn)
- 7.4 Media and Reagent Market
- 7.4.1 Overview
- 7.4.2 Asia Pacific Media and Reagent Market Revenue And Forecasts To 2027(US$ Mn)
- 7.5 Equipment
- 7.5.1 Overview
- 7.5.2 Asia Pacific Equipment Market Revenue And Forecasts To 2027 (US$ Mn)
8. Asia Pacific Cell Line Development Market Analysis – By Application
- 8.1 Overview
- 8.2 Asia Pacific Cell Line Development Market, by Application, 2018 & 2027 (%)
- 8.3 Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 8.4 Bioproduction
- 8.4.1 Overview
- 8.4.2 Asia Pacific Bioproduction Market Revenue And Forecasts To 2027(US$ Mn)
- 8.5 Drug Discovery
- 8.5.1 Overview
- 8.5.2 Asia Pacific Drug Discovery Market Revenue And Forecasts To 2027 (US$ Mn)
- 8.6 Tissue Engineering
- 8.6.1 Overview
- 8.6.2 Asia Pacific Tissue Engineering Market Revenue And Forecasts To 2027 (US$ Mn)
9. Asia Pacific Cell Line Development Market Revenue and Forecasts to 2027
- 9.1 Overview
- 9.2 Asia Pacific Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.3 Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By type (US$ Mn)
- 9.4 Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 9.5 Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.6 Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By Country (%)
- 9.7 China Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.7.1 China Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.7.2 China Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.7.3 China Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 9.7.4 China Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.8 Japan Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.8.1 Japan Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.8.2 Japan Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.8.3 Japan Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 9.8.4 Japan Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.9 India Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.9.1 India Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.9.2 India Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.9.3 India Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 9.9.4 India Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.10 South Korea Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.10.1 South Korea Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.10.2 South Korea Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.10.3 South Korea Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 9.10.4 South Korea Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
- 9.11 Australia Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.11.1 Australia Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.11.2 Australia Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 9.11.3 Australia Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
- 9.11.4 Australia Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10. Cell Line Development Market –Industry Landscape
- 10.1 Overview
- 10.2 Growth Strategies in the Cell Line Development Market, (%)
- 10.3 Organic Developments
- 10.3.1 Overview
- 10.3.2 Organic Growth Strategies in the Cell Line Development Market, 2016-2019
- 10.3.3 Expansion
- 10.3.3.1 Recent Expansion By Players In The Cell Line Development Market
- 10.3.4 Inorganic developments
- 10.3.5 Overview
- 10.3.6 Inorganic Growth Strategies In The Cell Line Development Market, 2016-2019
- 10.3.7 Agreements
- 10.3.7.1 The Cell Line Development Market, By Agreements
- 10.3.8 Acquisitions
- 10.3.8.1 Acquisitions By Players In The Cell Line Development Market
- 10.4 Source: The Insight Partners Analysis
11. Cell Line Development Market–Key Company Profiles
- 11.1 Merck KGaA
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Financial Overview
- 11.1.4 Product Portfolio
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
- 11.2 Thermo Fisher Scientific, Inc.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Financial Information
- 11.2.4 Product /Services Portfolio
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
- 11.3 Sartorius AG
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Financial Overview
- 11.3.4 Product Portfolio
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
- 11.4 SELEXIS
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Financial Overview
- 11.4.4 Product/Service Portfolio
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
- 11.5 BioFactura, Inc.
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Financial Overview
- 11.5.4 Product Portfolio
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
- 11.6 WuXi AppTec
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Financial Overview
- 11.6.4 Service Portfolio
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
- 11.7 LakePharma, Inc.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Financial Overview
- 11.7.4 Product Portfolio
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
- 11.8 General Electric
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Financial Overview
- 11.8.4 Product Portfolio
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
- 11.9 Lonza
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Financial Information
- 11.9.4 Product Portfolio
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
- 11.10 Corning Incorporated
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Financial Overview
- 11.10.4 Product Portfolio
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
- 11.11
12. Appendix
- 12.1 About The Insight Partners
- 12.2 Glossary of Terms
- 12.3 Methodology
- 12.3.1 Coverage
- 12.3.2 Secondary Research
- 12.3.3 Primary Research
Summary:
Get latest Market Research Reports on Asia Pacific Cell Line Development . Industry analysis & Market Report on Asia Pacific Cell Line Development is a syndicated market report, published as Asia Pacific Cell Line Development Market to 2027 - Regional Analysis and Forecasts by Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bioproduction and Tissue Engineering); and Geography. It is complete Research Study and Industry Analysis of Asia Pacific Cell Line Development market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
